Presentation is loading. Please wait.

Presentation is loading. Please wait.

Elevated levels of both myeloperoxidase (MPO) and oxidative α1-antitrypsin (oxAT) are associated with high high-sensitivity C-reactive protein (hsCRP)

Published byJustin Langevin Modified over 5 years ago

Similar presentations

Presentation on theme: "Elevated levels of both myeloperoxidase (MPO) and oxidative α1-antitrypsin (oxAT) are associated with high high-sensitivity C-reactive protein (hsCRP)"— Presentation transcript:

1 Elevated levels of both myeloperoxidase (MPO) and oxidative α1-antitrypsin (oxAT) are associated with high high-sensitivity C-reactive protein (hsCRP) and increasing carotid intima-media thickness (CIMT), whereas elevated oxAT alone contributes to decrease ... Elevated levels of both myeloperoxidase (MPO) and oxidative α1-antitrypsin (oxAT) are associated with high high-sensitivity C-reactive protein (hsCRP) and increasing carotid intima-media thickness (CIMT), whereas elevated oxAT alone contributes to decrease in geriatric nutritional risk index. Hirokazu Honda et al. CJASN 2009;4: ©2009 by American Society of Nephrology

Download ppt "Elevated levels of both myeloperoxidase (MPO) and oxidative α1-antitrypsin (oxAT) are associated with high high-sensitivity C-reactive protein (hsCRP)"

Similar presentations

Arterioscler Thromb Vasc Biol

Arterioscler Thromb Vasc Biol
Among Medicare beneficiaries >65 years old with a index hospitalization at the time of dialysis initiation, use of post-acute SNF care was common. Among.

Among Medicare beneficiaries >65 years old with a index hospitalization at the time of dialysis initiation, use of post-acute SNF care was common. Among.
Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.

Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.
بعض النقاط التي تؤخذ في الحسبان عند تقييم الاستثمارات الزراعية

بعض النقاط التي تؤخذ في الحسبان عند تقييم الاستثمارات الزراعية
Missense mutations in TNXB as a cause of VUR

Missense mutations in TNXB as a cause of VUR
Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.

Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.
Adjusted rate ratios of hospital days and admissions for blacks and Hispanics compared with whites by age group. Adjusted rate ratios of hospital days.

Adjusted rate ratios of hospital days and admissions for blacks and Hispanics compared with whites by age group. Adjusted rate ratios of hospital days.
Baseline Characteristics, Values at 24-Month Follow-up, and Changes from Baseline* - Part I John J.P. Kastelein, et al. N Engl J Med 2007;356: online.

Baseline Characteristics, Values at 24-Month Follow-up, and Changes from Baseline* - Part I John J.P. Kastelein, et al. N Engl J Med 2007;356: online.
Study Participant Flow

Study Participant Flow
Parathyroid hormone (PTH) levels by Dialysis Outcomes and Practice Patterns Study (DOPPS) phase and selected patient characteristics. Parathyroid hormone.

Parathyroid hormone (PTH) levels by Dialysis Outcomes and Practice Patterns Study (DOPPS) phase and selected patient characteristics. Parathyroid hormone.
Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.

Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.
Correlation of change in H2 concentration (△H2) haemodynamics or laboratory parameters. Correlation of change in H2 concentration (△H2) haemodynamics or.

Correlation of change in H2 concentration (△H2) haemodynamics or laboratory parameters. Correlation of change in H2 concentration (△H2) haemodynamics or.
PTA for AUC/MIC ratio ≥800 for each 48-hour AUC: AUC0 to 48 (A), AUC48 to 96 (B), and AUC96 to 144 (C). PTA for AUC/MIC ratio ≥800 for each 48-hour AUC:

PTA for AUC/MIC ratio ≥800 for each 48-hour AUC: AUC0 to 48 (A), AUC48 to 96 (B), and AUC96 to 144 (C). PTA for AUC/MIC ratio ≥800 for each 48-hour AUC:
Lower atherosclerotic burden in familial abdominal aortic aneurysm

Lower atherosclerotic burden in familial abdominal aortic aneurysm
Thirty-day survival curves for the rapid versus slow correction rate groups are not significantly different. Thirty-day survival curves for the rapid versus.

Thirty-day survival curves for the rapid versus slow correction rate groups are not significantly different. Thirty-day survival curves for the rapid versus.
Forest plot of CIMT progression rate for atorvastatin treatment versus placebo for 3 years by baseline serum 25-hydroxyvitamin D status. Forest plot of.

Forest plot of CIMT progression rate for atorvastatin treatment versus placebo for 3 years by baseline serum 25-hydroxyvitamin D status. Forest plot of.
Conceptual model of the course of chronic kidney disease (CKD).

Conceptual model of the course of chronic kidney disease (CKD).
Drug levels during the course of a dosing interval.

Drug levels during the course of a dosing interval.
(A) Mean (SD) serum continuous erythropoietin receptor activator (C. E

(A) Mean (SD) serum continuous erythropoietin receptor activator (C. E
Adjusted means (±SD) of eGFR in relation to the histologic severity of nonalcoholic steatohepatitis (i.e., NASH/fibrosis stage increasing from 0 to 3)

Adjusted means (±SD) of eGFR in relation to the histologic severity of nonalcoholic steatohepatitis (i.e., NASH/fibrosis stage increasing from 0 to 3)

Similar presentations

Ads by Google